Stella Pharma Corporation (TYO:4888)
Japan · Delayed Price · Currency is JPY 470.00
+1.00 (0.21%)
At close: Mar 6, 2026
Stella Pharma Market Cap
Stella Pharma has a market cap or net worth of 16 billion as of March 6, 2026. Its market cap has increased by 5.62% in one year.
Market Cap
16.00B
Enterprise Value
14.09B
Revenue
968.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
470.00
Market Cap Chart
Since April 22, 2021, Stella Pharma's market cap has decreased from 23.73B to 16.00B, a decrease of -32.59%. That is a compound annual growth rate of -7.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 16.00B | 131.53% |
| Dec 30, 2025 | 6.91B | -62.20% |
| Dec 30, 2024 | 18.28B | 105.37% |
| Dec 29, 2023 | 8.90B | -22.42% |
| Dec 30, 2022 | 11.47B | -56.48% |
| Dec 30, 2021 | 26.35B | 11.06% |
| Apr 22, 2021 | 23.73B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Renascience | 25.78B |
| RaQualia Pharma | 23.08B |
| AnGes | 22.55B |
| StemRIM | 18.62B |
| ReproCELL | 16.76B |
| Kubota Pharmaceutical Holdings | 15.58B |
| CanBas | 15.21B |
| Nano Holdings | 13.50B |